Accurate Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Buy
4,440
+30
+0.7% +$5.64K 0.07% 262
2026
Q1
$900K Sell
4,410
-28
-0.6% -$5.4K 0.11% 208
2025
Q4
$840K Buy
4,438
+150
+3% +$26.3K 0.11% 204
2025
Q3
$730K Buy
4,288
+39
+0.9% +$5.9K 0.1% 223
2025
Q2
$610K Buy
4,249
+3
+0.1% +$420 0.09% 225
2025
Q1
$563K Buy
4,246
+14
+0.3% +$2.03K 0.11% 192
2024
Q4
$567K Buy
4,232
+138
+3% +$19.3K 0.11% 186
2024
Q3
$637K Buy
4,094
+112
+3% +$18.1K 0.13% 160
2024
Q2
$622K Buy
3,982
+32
+0.8% +$4.82K 0.15% 144
2024
Q1
$542K Buy
3,950
+20
+0.5% +$2.65K 0.16% 140
2023
Q4
$544K Buy
3,930
+1
+0% +$130 0.17% 124
2023
Q3
$544K Sell
3,929
-22
-0.6% -$3K 0.17% 127
2023
Q2
$532K Sell
3,951
-101
-2% -$14.9K 0.17% 126
2023
Q1
$584K Buy
4,052
+3,842
+1,830% +$517K 0.2% 119
2022
Q4
$30.1K Buy
+210
New +$26.3K 0.01% 568

Other funds holding AZN

Accurate Wealth Management's AZN Position: Q2 2026 in Review

Accurate Wealth Management increased its AstraZeneca (AZN) stake by 0.68% in Q2 2026, buying an estimated $5.64K and bringing the position to 4,440 shares worth $763K. The position accounts for 0.07% of the portfolio, ranked #262.

Accurate Wealth Management first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $900K in Q1 2026. 502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Accurate Wealth Management held 4,440 shares of AstraZeneca worth $763K as of Q2 2026.
  • Accurate Wealth Management bought 30 AstraZeneca shares in Q2 2026, an estimated $5.64K.
  • AstraZeneca made up 0.07% of Accurate Wealth Management's portfolio in Q2 2026, its #262 holding.
  • Accurate Wealth Management first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
  • Accurate Wealth Management's AstraZeneca position peaked at $900K in Q1 2026.
  • 502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.